The 5-HT1A and 5-HT1B receptors also play roles in glial cell formation associated with PD and motor disorders: levodopa combined with 5-HT1A/1B receptor agonists treated PD-induced motor disorders in rats and delayed the occurrence of neuroinflammatory markers in the nigrostriatal system [110]. This evidence concerns the gene HTR1A and Parkinson disease.